Amyloid PET quantification using low-dose CT-guided anatomic standardization.

Autor: Matsuda H; Department of Biofunctional Imaging, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan. hiroshi.matsuda@mt.strins.or.jp.; Drug Discovery and Cyclotron Research Center, Southern Tohoku Research Institute for Neuroscience, 7-61-2 Yatsuyamada, Koriyama, Fukushima, 963-8052, Japan. hiroshi.matsuda@mt.strins.or.jp.; Department of Radiology, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8551, Japan. hiroshi.matsuda@mt.strins.or.jp.; Department of Biofunctional Imaging, Fukushima Medical University, 6F(621), Shin-Otemachi Building, 2-2-1, Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan. hiroshi.matsuda@mt.strins.or.jp., Yamao T; Drug Discovery and Cyclotron Research Center, Southern Tohoku Research Institute for Neuroscience, 7-61-2 Yatsuyamada, Koriyama, Fukushima, 963-8052, Japan.; Department of Radiological Sciences, School of Health Sciences, Fukushima Medical University, 10-6, Sakae, Fukushima, 960-8516, Japan., Shakado M; Department of Radiology, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8551, Japan., Shigemoto Y; Drug Discovery and Cyclotron Research Center, Southern Tohoku Research Institute for Neuroscience, 7-61-2 Yatsuyamada, Koriyama, Fukushima, 963-8052, Japan.; Department of Radiology, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8551, Japan., Okita K; Integrative Brain Imaging Center, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8551, Japan., Sato N; Department of Radiology, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8551, Japan.
Jazyk: angličtina
Zdroj: EJNMMI research [EJNMMI Res] 2021 Dec 14; Vol. 11 (1), pp. 125. Date of Electronic Publication: 2021 Dec 14.
DOI: 10.1186/s13550-021-00867-7
Abstrakt: Background: Centiloid (CL) scaling has become a standardized quantitative measure in amyloid PET because it facilitates the direct comparison of results across institutions, even when different analytical methods or tracers are used. Standard volumes of interest must be used to calculate the CL scale after the anatomic standardization of amyloid PET images using coregistered MRI; if the MRI is unavailable, the CL scale cannot be accurately calculated. This study sought to determine the substitutability of low-dose CT, which is used to correct PET attenuation in PET/CT equipment, by evaluating the measurement accuracy when low-dose CT is used as an alternative to MRI in the calculation of the CL scale. Amyloid PET images obtained using 18 F-flutemetamol from 24 patients with possible or probable Alzheimer's disease were processed to calculate the CL scale using 3D T1-weighted MRI and low-dose CT of PET/CT. CL MRI and CL CT were, respectively, defined as the use of MRI and CT for anatomic standardization and compared. Regional differences in the CT-based and MRI-based standardized anatomic images were also investigated.
Trial Registration: Japan Registry of Clinical Trials, jRCTs031180321 (registered 18 March 2019, https://jrct.niph.go.jp/latest-detail/jRCTs031180321 ).
Results: A Bland-Altman plot showed that CL CT was slightly but significantly underestimated (mean ± standard deviation, - 1.7 ± 2.4; p < 0.002) compared with CL MRI . The 95% limits of agreement ranged from - 2.8 to - 0.7. Pearson correlation analysis showed a highly significant correlation of r = 0.998 between CL CT and CL MRI (p < 0.001). The linear regression equation was CL MRI  = 1.027 × CL CT  + 0.762. In a Bland-Altman plot, Spearman correlation analysis did not identify a significant association between the difference in CL MRI versus CL CT and CL load (ρ =  - 0.389, p = 0.060). This slight underestimation of CL CT may derive from slightly higher uptake when the cerebellum is used as a reference area in CT-based anatomically standardized PET images versus MRI-based images.
Conclusions: Low-dose CT of PET/CT can substitute for MRI in the anatomic standardization used to calculate the CL scale from amyloid PET, although a slight underestimation occurs.
(© 2021. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje